ADAM VTE (apixaban for cancer-associated VTE) results have been published - let's talk about it. Also, what are the implications of long term ibrutinib on CV health? A new Blood paper offers some possible answers.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.